BSE Live
Oct 03, 16:01Prev. Close
402.15
Open Price
399.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:58Prev. Close
401.00
Open Price
403.00
Bid Price (Qty.)
415.25 (101)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | |
Total Share Capital | 6.13 | 12.12 | 11.11 | 10.27 | 9.57 | |
Reserves and Surplus | 828.66 | 814.27 | 815.82 | 842.67 | -256.47 | |
Total Reserves and Surplus | 828.66 | 814.27 | 815.82 | 842.67 | -256.47 | |
Total Shareholders Funds | 834.79 | 826.39 | 826.93 | 852.94 | -246.90 | |
Minority Interest | -4.17 | -3.82 | -3.49 | -2.98 | -3.00 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 22.21 | 15.00 | 15.18 | 29.96 | 731.63 | |
Deferred Tax Liabilities [Net] | 23.28 | 22.55 | 20.37 | 0.00 | 0.00 | |
Other Long Term Liabilities | 11.31 | 22.28 | 32.14 | 70.59 | 194.41 | |
Long Term Provisions | 35.34 | 27.80 | 26.55 | 29.24 | 55.36 | |
Total Non-Current Liabilities | 92.14 | 87.62 | 94.24 | 129.78 | 981.40 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.06 | 0.05 | 0.00 | |
Trade Payables | 225.76 | 153.68 | 177.32 | 259.78 | 221.94 | |
Other Current Liabilities | 104.88 | 119.46 | 118.31 | 530.55 | 190.37 | |
Short Term Provisions | 36.35 | 35.69 | 36.14 | 12.39 | 13.35 | |
Total Current Liabilities | 366.99 | 308.83 | 331.83 | 802.77 | 425.66 | |
Total Capital And Liabilities | 1,289.75 | 1,240.67 | 1,271.17 | 1,782.51 | 1,178.82 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 593.73 | 572.63 | 588.33 | 587.81 | 606.65 | |
Intangible Assets | 7.72 | 9.22 | 11.62 | 1.47 | 2.05 | |
Capital Work-In-Progress | 93.51 | 74.72 | 28.01 | 4.91 | 21.24 | |
Fixed Assets | 694.96 | 683.35 | 642.28 | 606.54 | 643.12 | |
Non-Current Investments | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 30.17 | 0.15 | |
Long Term Loans And Advances | 0.00 | 0.09 | 0.30 | 0.00 | 1.22 | |
Other Non-Current Assets | 49.54 | 71.99 | 60.20 | 105.17 | 23.29 | |
Total Non-Current Assets | 744.57 | 755.49 | 702.85 | 741.96 | 667.84 | |
CURRENT ASSETS | ||||||
Current Investments | 3.15 | 40.36 | 13.42 | 5.00 | 0.00 | |
Inventories | 213.67 | 177.94 | 202.09 | 212.72 | 174.14 | |
Trade Receivables | 72.56 | 57.42 | 60.09 | 131.66 | 84.68 | |
Cash And Cash Equivalents | 106.97 | 139.48 | 225.99 | 583.28 | 135.79 | |
Short Term Loans And Advances | 2.57 | 3.18 | 1.58 | 1.44 | 4.29 | |
OtherCurrentAssets | 146.26 | 66.80 | 65.15 | 106.45 | 112.06 | |
Total Current Assets | 545.18 | 485.18 | 568.32 | 1,040.55 | 510.97 | |
Total Assets | 1,289.75 | 1,240.67 | 1,271.17 | 1,782.51 | 1,178.82 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 378.95 | 644.43 | 373.48 | 413.45 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.00 | 1.81 | 1.81 | 1.81 | 1.81 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.07 | 0.07 | 0.07 | 0.07 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y